TOV-21G(人卵巢癌细胞)
CBP60292
询 价
索取STR
产品描述
产品数据库
I. General information | |
Synonyms: | TOV-21G |
Background: | This cell line was initiated in October of 1991 from a patient of French-Canadian descent with no family history of ovarian cancer. |
Species: | Homo sapiens, human |
Tissue: | ovary |
Disease: | grade 3, stage III,primary malignant adenocarcinoma; clear cell carcinoma |
Gender: | female, 62 years, |
Morphology: | epithelial |
Growth Mode: | adherent |
DNA Profile: | Amelogenin: X CSF1PO: 13,15 D13S317: 11,12 D16S539: 10,12 D5S818: 12,13 D7S820: 12 THO1: 7,9.3 TPOX: 8,11 vWA: 17 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
1:1 mixture of MCDB 105 medium and Medium 199,85%; FBS,15% TOV-21G完全培养基,# CBP60292M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Oncogene: | p53 + (wild type) |
Genes Expressed: | keratin |
Cellular Products: | keratin |
Tumor Formation: | Yes, form colonies in soft agar Yes, the cells are tumorigenic in nude mice |
Comments: | Like OV-90 (ATCC CRL-11732), the OV-21G (ATCC CRL-11730) cell line exhibits a deletion at chromosome 3p24. The TOV-112D (ATCC CRL-11731) cell line does not exhibit a deletion at chromosome 3p24. For more information, please contact Cobioer (4008-750-250). |